Italian daily Il Messaggero today has reported that Angelini is the most likely candidate to acquire its French competitor Upsa, belonging to US-based Bristol-Myers Squibb. The article mentions as sources the banks hired to manage the transaction. Four companies have submitted their offers, the most eligible being the Italian group’s one. The three other bidders are Germany-based Stada and private equities CVC and PAI Partners.
(Source Il Messaggero)